LCHAD deficiency is an autosomal recessive trait and affected infants present in infancy with acute hypoketotic hypoglycemia
These nano-based strategies not only optimize pharmacokinetics and therapeutic efficacy, but also hold potential for non-invasive delivery routes, including oral, buccal, transdermal, and pulmonary administration
Hearing loss and consequential impairment of childhood psychosocial and cognitive development are common complications of CSOM in children (Monasta et al., 2012) and although rare, neurological sequelae account for 21,000 deaths annually (Monasta et al., 2012
Owing to restrictions on the purchase of AAS and PCT products, an international black market for such preparations has developed
Lip C peptide remains in research and has not been approved by regulatory agencies or made available through clinical pharmacies